Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study All patients were seen by one of the investigators at Columbia University, and patients who received ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback